2025-2026 Regular Session • US Congress Legislature
SB1631
Legislative Summary
A bill to require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.
Bill History
5/6/2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Senate
Status Information
Current Status
Introduced(5/6/2025)
Chamber
Senate
Committee
Health, Education, Labor, And Pensions(Senate)
Sponsors
Republican: 1
Primary Sponsor
Josh Hawley
Republican